Clinical Trial Update: A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating the efficacy and tolerability of the TEGAFOX sequential S-1 regimen as adjuvant chemotherapy for gastric cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)
• TEGAFOX

Snippet

Sponsor: LanZhou University | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: UNKNOWN